ANZEMET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Anzemet, and what generic alternatives are available?
Anzemet is a drug marketed by Validus Pharms and is included in two NDAs.
The generic ingredient in ANZEMET is dolasetron mesylate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dolasetron mesylate profile page.
Summary for ANZEMET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Clinical Trials: | 4 |
Patent Applications: | 5,127 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ANZEMET |
What excipients (inactive ingredients) are in ANZEMET? | ANZEMET excipients list |
DailyMed Link: | ANZEMET at DailyMed |
Recent Clinical Trials for ANZEMET
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
David A. Clump, MD, PhD | Phase 2 |
University of Pittsburgh | Phase 2 |
National Cancer Institute (NCI) | N/A |
Pharmacology for ANZEMET
Drug Class | Serotonin-3 Receptor Antagonist |
Mechanism of Action | Serotonin 3 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for ANZEMET
US Patents and Regulatory Information for ANZEMET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Validus Pharms | ANZEMET | dolasetron mesylate | INJECTABLE;INJECTION | 020624-002 | Sep 11, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | ANZEMET | dolasetron mesylate | TABLET;ORAL | 020623-001 | Sep 11, 1997 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | ANZEMET | dolasetron mesylate | INJECTABLE;INJECTION | 020624-001 | Sep 11, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | ANZEMET | dolasetron mesylate | INJECTABLE;INJECTION | 020624-003 | Dec 11, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | ANZEMET | dolasetron mesylate | TABLET;ORAL | 020623-002 | Sep 11, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ANZEMET
International Patents for ANZEMET
See the table below for patents covering ANZEMET around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2061469 | ⤷ Try a Trial | |
Israel | 84309 | ESTERS OF HEXAHYDRO-8-HYDROXY-2,6-METHANO-2H-QUINO-LIZIN-3(4H)-ONE AND RELATED COMPOUNDS,PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Try a Trial |
Finland | 87786 | ⤷ Try a Trial | |
Germany | 3639353 | ⤷ Try a Trial | |
European Patent Office | 0329903 | ⤷ Try a Trial | |
Netherlands | 970043 | ⤷ Try a Trial | |
Greece | 3018299 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ANZEMET
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0266730 | SPC/GB97/005 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DOLASETRON, OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION OR QUATERNARY AMMONIUM SALT THEREOF; REGISTERED: UK 04425/0150 19960926 |
0266730 | C970043 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DOLASETRON, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESYLAAT; NAT REGISTRATION NO/DATE: RVG 21707 - RVG 21709 19970623; FIRST REGISTRATION: GB PL 04425/0150, PL 04425/0152, PL 04425/0154 19960926 |
0266730 | 73/1997 | Austria | ⤷ Try a Trial | PRODUCT NAME: ANZEMET; NAT. REGISTRATION NO/DATE: 1-22014, 1-22015, 1-22016 19970624; FIRST REGISTRATION: GB PL 04425/0150 19960926 |
0266730 | 98C0014 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MIGLITOL; NAT. REGISTRATION NO/DATE: NL 22 138 19970204; FIRST REGISTRATION: NL - 19 343 UR 19960723 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |